Amicus Therapeutics, Inc. (FOLD) Social Stream
AMICUS THERAPEUTICS INC (FOLD) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering AMICUS THERAPEUTICS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-10 | 11 | $29 | $12 | $18 | $13.35 | 34.83% |
| 2021-11-15 | 10 | $29 | $12 | $18.444 | $13.35 | 38.16% |
| 2021-11-23 | 10 | $29 | $12 | $18.555 | $13.35 | 38.99% |
| 2022-01-13 | 9 | $29 | $12 | $17.375 | $13.35 | 30.15% |
| 2022-01-17 | 9 | $29 | $15 | $17.875 | $13.35 | 33.9% |
| 2022-01-26 | 9 | $29 | $15 | $17.5 | $13.35 | 31.09% |
| 2022-02-25 | 9 | $29 | $14 | $17 | $13.35 | 27.34% |
| 2022-04-20 | 9 | $20 | $14 | $15.5 | $13.35 | 16.1% |
| 2022-05-10 | 10 | $20 | $11 | $15 | $13.35 | 12.36% |
| 2022-05-12 | 8 | $20 | $11 | $15.125 | $13.35 | 13.3% |
| 2022-08-05 | 7 | $20 | $11 | $15 | $13.35 | 12.36% |
| 2022-08-13 | 7 | $20 | $11 | $15.142 | $13.35 | 13.42% |
| 2022-10-19 | 8 | $20 | $11 | $15 | $13.35 | 12.36% |
| 2022-11-07 | 8 | $20 | $11 | $15.125 | $13.35 | 13.3% |
| 2022-11-15 | 8 | $20 | $11 | $15.428 | $13.35 | 15.57% |
| 2023-01-16 | 8 | $20 | $11 | $15.375 | $13.35 | 15.17% |
| 2023-02-08 | 8 | $20 | $11 | $15.875 | $13.35 | 18.91% |
| 2023-03-03 | 9 | $20 | $11 | $16.111 | $13.35 | 20.68% |
| 2023-04-12 | 9 | $20 | $11 | $16.222 | $13.35 | 21.51% |
| 2023-07-11 | 8 | $20 | $11 | $16.111 | $13.35 | 20.68% |
| 2023-08-09 | 8 | $20 | $11 | $16.222 | $13.35 | 21.51% |
| 2023-08-10 | 8 | $20 | $11 | $16.333 | $13.35 | 22.34% |
| 2023-09-26 | 8 | $20 | $11 | $16.444 | $13.35 | 23.18% |
| 2023-09-29 | 8 | $20 | $11 | $16.555 | $13.35 | 24.01% |
| 2023-09-30 | 8 | $21 | $11 | $17.555 | $13.35 | 31.5% |
| 2023-11-08 | 8 | $21 | $11 | $17.444 | $13.35 | 30.67% |
| 2023-11-10 | 8 | $21 | $11 | $17.777 | $13.35 | 33.16% |
| 2023-11-29 | 8 | $21 | $11 | $18 | $13.35 | 34.83% |
| 2023-12-14 | 9 | $21 | $14 | $18.333 | $13.35 | 37.33% |
| 2023-12-19 | 9 | $21 | $14 | $18.888 | $13.35 | 41.48% |
The Trend in the Analyst Price Target
Over the past 43 months, FOLD's average price target has gone up $0.57.
FOLD reports an average of 39.01% for its upside potential over the past 48 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-08 | 8 | 20 | 11 | 15.875 | 12.58 | 26.19% |
| 2023-04-11 | 9 | 20 | 11 | 16.222 | 11.20 | 44.84% |
| 2023-05-12 | 8 | 20 | 11 | 16.111 | 11.29 | 42.7% |
| 2023-09-26 | 8 | 20 | 11 | 16.444 | 12.24 | 34.35% |
| 2023-09-29 | 8 | 20 | 11 | 17.000 | 12.16 | 39.8% |
FOLD Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.22 | 8 | 0 | 1 | 0 | 0 | 9 |
The Trend in the Broker Recommendations
FOLD's average broker recommendation rating improved by 0.03 over the prior 31 weeks.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for FOLD as an investment opportunity.
- In the context of all US stocks, AMICUS THERAPEUTICS INC's average analyst price target is higher than 758.73% of them.
- In terms of how AMICUS THERAPEUTICS INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -2503.54% of that group.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, AMICUS THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 945.35% of them.
- In the context of Pharmaceutical Products stocks, AMICUS THERAPEUTICS INC's number of analysts covering the stock is higher than 2231.01% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to AMICUS THERAPEUTICS INC are ENTA, MDGL, and MGNX.
View All Top Stocks by Price Target
Make investment decisions regarding FOLD using the data that counts. Try POWR Ratings for free.